- Home
- ANNX vs BRT Comparison
ANNX vs BRT Comparison
Compare ANNX & BRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANNX
- BRT
- Stock Information
- Founded
- ANNX 2011
- BRT 1972
- Country
- ANNX United States
- BRT United States
- Employees
- ANNX N/A
- BRT N/A
- Industry
- ANNX Biotechnology: Pharmaceutical Preparations
- BRT Real Estate Investment Trusts
- Sector
- ANNX Health Care
- BRT Real Estate
- Exchange
- ANNX Nasdaq
- BRT Nasdaq
- Market Cap
- ANNX 253.8M
- BRT 288.5M
- IPO Year
- ANNX 2020
- BRT N/A
- Fundamental
- Price
- ANNX $2.64
- BRT $16.33
- Analyst Decision
- ANNX Strong Buy
- BRT Strong Buy
- Analyst Count
- ANNX 5
- BRT 1
- Target Price
- ANNX $13.00
- BRT $21.00
- AVG Volume (30 Days)
- ANNX 1.6M
- BRT 24.3K
- Earning Date
- ANNX 11-13-2025
- BRT 11-06-2025
- Dividend Yield
- ANNX N/A
- BRT 6.20%
- EPS Growth
- ANNX N/A
- BRT N/A
- EPS
- ANNX N/A
- BRT N/A
- Revenue
- ANNX N/A
- BRT $98,407,000.00
- Revenue This Year
- ANNX N/A
- BRT N/A
- Revenue Next Year
- ANNX N/A
- BRT $4.51
- P/E Ratio
- ANNX N/A
- BRT N/A
- Revenue Growth
- ANNX N/A
- BRT 2.46
- 52 Week Low
- ANNX $1.29
- BRT $14.17
- 52 Week High
- ANNX $7.85
- BRT $20.22
- Technical
- Relative Strength Index (RSI)
- ANNX 62.43
- BRT 58.70
- Support Level
- ANNX $2.32
- BRT $16.01
- Resistance Level
- ANNX $2.70
- BRT $16.51
- Average True Range (ATR)
- ANNX 0.16
- BRT 0.39
- MACD
- ANNX 0.06
- BRT 0.05
- Stochastic Oscillator
- ANNX 87.57
- BRT 70.20
About ANNX Annexon Inc.
Annexon Inc is a clinical-stage biopharmaceutical company developing a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, brain, and eye. Its pipeline is based on its platform technology addressing well-researched classical complement-mediated autoimmune and neurodegenerative disease processes, both of which are triggered by aberrant activation of C1q. Its pipeline of product candidates is designed to block the activity of C1q and the entire classical complement pathway in a broad set of complement-mediated diseases. Its product candidates are ANX005, for autoimmune & neurodegenerative disorders; ANX007, for neurodegenerative ophthalmic disorders; ANX1502 for Oral small molecule; and ANX009, for systemic autoimmune diseases.
About BRT BRT Apartments Corp. (MD)
BRT Apartments Corp is a real estate investment trust company. The company is focused on the ownership, operation, and development of multi-family properties. BRT also owns and operates other real estate assets. All of the Company's assets are comprised of multi-family real estate assets generally leased to tenants on a one-year basis.